Your activity: 2 p.v.

Management of the patient with dementia

Management of the patient with dementia
Author:
Daniel Press, MD
Section Editors:
Steven T DeKosky, MD, FAAN, FACP, FANA
Kenneth E Schmader, MD
Mario F Mendez, MD, PhD
Deputy Editors:
Janet L Wilterdink, MD
Jane Givens, MD, MSCE
Literature review current through: Dec 2022. | This topic last updated: Dec 22, 2021.

INTRODUCTION — Advances in the understanding of the pathophysiology of neurodegenerative dementias hold promise for disease-specific and, hopefully, disease-modifying treatments. However, at present, the mainstay of treatment is symptomatic management. In this regard, important management issues include treatment of behavioral disturbances, environmental manipulations to support function, and counseling with respect to safety issues. A close discussion with the patient's caregiver is essential.

Available options for the management of dementia are discussed here. This topic review will also discuss the recognition and management of safety and societal issues related to dementia, including decision-making capacity, driving, financial capacity, cooking, wandering and becoming lost, falls, and living alone.

The management of neuropsychiatric symptoms of dementia and palliative care of patients with advanced dementia are discussed separately.

(See "Management of neuropsychiatric symptoms of dementia".)

(See "Care of patients with advanced dementia".)

Other topic reviews discuss the evaluation of patients with cognitive impairment and dementia, as well as the risk factors and prevention of dementia.

(See "Evaluation of cognitive impairment and dementia".)

(See "Risk factors for cognitive decline and dementia".)

(See "Prevention of dementia".)

SPECIALTY-CARE REFERRAL — Timing of referral to a specialist depends upon the comfort and knowledge base of the primary care provider in managing dementia and on the availability of specialty clinics where additional resources are available, such as social workers and neuropsychologists.

The first step in management is an accurate diagnosis of the type of dementia. Thus, one factor that would be important in considering patient referral is uncertainty about the diagnosis of an early dementia (eg, when difficulty arises distinguishing dementia from normal aging, depression, or encephalopathy), when a non-Alzheimer dementia is likely (early and severe behavioral changes, language problems, hallucinations, or parkinsonism), when there is a young onset (<65 years old), and when there is a strong family history. (See "Evaluation of cognitive impairment and dementia".)

In addition, some patients benefit from multidisciplinary care. Patients with behavioral variant frontotemporal dementia (FTD), for example, may benefit from specialist care to manage disinhibition and other behavioral manifestations. Those with Lewy body dementia also generally require specialty care to manage complex motor and nonmotor symptoms.

MEDICAL THERAPY — The management of medical problems can be more complex in patients with dementia [1]. Patients with dementia have a decreased ability to make decisions, to adhere to treatment plans (including medication compliance), and to report adverse effects of therapy [2,3].

Disease-specific treatments — Issues specific to the management of specific dementia syndromes are discussed in individual topic reviews.

As examples:

(See "Treatment of Alzheimer disease".)

(See "Prognosis and treatment of dementia with Lewy bodies".)

(See "Treatment of vascular cognitive impairment and dementia".)

(See "Frontotemporal dementia: Treatment".)

Neuropsychiatric symptoms — Some patients with severe behavioral disturbances and other neuropsychiatric symptoms may benefit from specific treatment. This topic is discussed separately. (See "Management of neuropsychiatric symptoms of dementia" and "Sleep-wake disturbances and sleep disorders in patients with dementia".)

Vascular risk factor control — Identification and treatment of risk factors for stroke, cardiovascular disease, and dementia may represent an important strategy for decreasing the incidence of dementia and for slowing the progression of cognitive decline, particularly for patients with vascular dementia and also those with Alzheimer disease (AD). (See "Treatment of vascular cognitive impairment and dementia", section on 'Vascular risk modification' and "Treatment of Alzheimer disease", section on 'Vascular risk factor management'.)

Data are not entirely consistent, however, and there are potential harms to overly aggressive risk factor management [4]. As an example, one study in 172 patients with dementia or mild cognitive impairment (MCI) found that Mini-Mental State Examination (MMSE) scores declined fastest in patients being treated with antihypertensive drugs who had the lowest tertile of daytime systolic blood pressures (≤128 mmHg) [5]. Orthostatic hypotension associated with overly aggressive blood pressure management is also of concern, particularly in patients with Parkinson disease (PD), who may have a measurable decline in cognition when standing [6]. We therefore suggest attention to standing blood pressure in patients with dementia who are being treated for hypertension.

These topics as they relate to the incidence and prevention of dementia are discussed separately. (See "Risk factors for cognitive decline and dementia" and "Prevention of dementia".)

Avoiding adverse drug effects — Adverse effects of prescribed medications can contribute to cognitive impairment and exacerbate dementia. In patients with dementia, it is important to periodically review the patient's drug regimen, use the minimal dose required to obtain clinical benefit, discontinue unnecessary therapies, consider adverse drug effects as a cause of a new symptom before prescribing another drug, and consider nonpharmacologic approaches when appropriate. Patients with dementia have a decreased ability to report adverse effects of therapy, requiring additional vigilance on the part of the clinician [2,3]. A systematic approach to drug prescribing in older patients is described separately. (See "Drug prescribing for older adults", section on 'A stepwise approach to prescribing' and "Deprescribing".)

Polypharmacy – Polypharmacy is very common in older adults, who may have multiple medical conditions and are at increased risk for adverse drug events due to metabolic changes and decreased drug clearance associated with aging. These risks are compounded by increasing numbers of drugs used. A diagnosis of dementia adds further vulnerability, not only to cognitive side effects but also to effects of drugs on balance, motor function, and bladder control. Any clinician who makes a medication change should notify all other clinicians who are actively following the patient, even if notes are auto-forwarded and/or if there is a common medication list.

Patients with dementia are also at risk for prescribing cascades, which occur when a new drug is prescribed to treat symptoms arising from an unrecognized side effect of an existing therapy. One common example relevant to patients with dementia is prescription of an anticholinergic therapy (eg, oxybutynin) to treat incontinence that develops after prescription of a cholinesterase inhibitor. (See "Drug prescribing for older adults", section on 'Prescribing cascades'.)

Drugs that can exacerbate impairment – Drugs of particular concern in adults with dementia include anticholinergic drugs (table 1), benzodiazepines, opioids, antipsychotic drugs, and antihypertensive drugs, especially in patients with PD and other disorders associated with autonomic dysfunction.

Despite these risks, data suggest that older adults with dementia are commonly prescribed potentially unsafe medications. In analysis of United States medication expenditures between 2005 and 2009, 23 percent of community-dwelling persons >65 years with dementia were prescribed medications with clinically significant anticholinergic activity [7]. In another large study that included over 75,000 adults with dementia in the United States Department of Veterans Affairs (VA) system, 44 percent of patients were prescribed at least one potentially unsafe medication (mostly drugs with high anticholinergic activity), and rates were consistently higher among patients receiving care from multiple providers (inside and outside the VA system) [8]. (See "Drug prescribing for older adults", section on 'Inappropriate medications'.)

NONPHARMACOLOGIC THERAPY AND SUPPORTIVE CARE

Nutrition — Weight changes in either direction can occur in patients with dementia, particularly in more advanced stages.

Inadequate nutrition is associated with increased morbidity and mortality [9]; interventions such as assisted feeding and oral nutritional supplements may improve weight and fat-free mass [10]. A systematic review found that provision of high-calorie supplements improved weight gain in patients with dementia; however, the limited available data did not support a benefit in regard to functional and survival outcomes [11]. Other interventions (appetite stimulants, assisted feeding) were less clearly associated with weight gain. We have noted that some patients can gain weight, perhaps from overuse of supplements; in such patients monitoring and restricting high caloric intake may be needed to maintain a healthy body weight.

Decreased sense of smell is also common in patients with dementia and can manifest itself as poor appetite and weight loss. This can sometimes be overcome by increasing other types of sensory stimulation. As an example, caregivers can try adding low-sodium soy sauce or salsa to foods, or using recipes aimed at increasing the flavor content of meals. Another strategy is to increase foods and spices that alter the texture and feel of food in the mouth, such as black pepper, paprika, hot peppers, ginger, mustards, radishes, or horseradish.

Despite these and other interventions, decreased food intake is common in patients with advanced dementia. Issues related to feeding problems and decisions regarding ongoing hand feeding versus tube feeding in patients with advanced dementia are discussed separately. (See "Care of patients with advanced dementia", section on 'Eating problems'.)

Rehabilitation — The multidisciplinary, nonpharmacologic approaches to management of dementia discussed in this section have significant advantages in having none of the side effects that significantly complicate drug treatment in this patient population. However, more research is needed to confirm benefits seen in these trials and to provide a standardized approach that can be applied in the general community.

Cognitive rehabilitation — Cognitive rehabilitation aims to help patients in the early stages of dementia to maintain memory and higher cognitive function and to devise strategies to compensate for declining function. Studies regarding the efficacy of this approach are limited by the lack of standardized techniques. A 2012 systematic review concluded that the studies to date provided evidence that cognitive stimulation programs benefit cognition, but that studies were of variable quality and further research is indicated [12]. This provides hope that cognitive remediation approaches are both feasible and of potential benefit in patients with dementia. However, it will be critical to show that improvements extend to other "real-life" tasks before these interventions can be endorsed. In general, cognitive rehabilitation is most efficacious when it is part of a multidomain intervention including exercise, diet, and addressing vascular risk factors [13].

Exercise programs — We encourage our patients with dementia to participate in regular exercise programs. A regular walk with a family member or caregiver or an exercise program at a senior center can be beneficial to patients.

Several small randomized studies have demonstrated that formal exercise programs may improve physical functioning or at least slow the progression of functional decline in patients with Alzheimer disease (AD) [14-17]; one also found reduced falls [17]. At the same time, these studies did not find that exercise programs improved cognitive functioning in adults with dementia, at least over the study duration [14-19].

Other studies suggest a modest benefit of exercise in mild cognitive impairment (MCI), at least in the short term. These are discussed separately. (See "Mild cognitive impairment: Prognosis and treatment", section on 'Exercise'.)

Occupational therapy — Occupational therapy is most likely to benefit patients when centers have a specific program designed for patients with dementia; such programs require specific training for the therapist. In the absence of this expertise, occupational therapy has an uncertain benefit.

In a randomized trial, 68 of 135 community-dwelling patients with mild to moderate dementia were assigned to receive 10 sessions of occupational therapy over five weeks [20]. Individualized therapy sessions focused on training patients and caregivers in the use of aids, coping behaviors, and other strategies to compensate for those functional deficits that were specifically problematic for the patient. Assessments of motor and process skills and activities of daily living (ADLs) were significantly improved compared with controls, both at six weeks and at three months, implying that the treatment has some durability. The intervention also appeared to be cost effective, specifically reducing costs of informal caregiving [21].

Alcohol use — Alcohol can exacerbate cognitive dysfunction and behavioral disturbance in patients with dementia. Patients with dementia, particularly those with mild AD, can sometimes drink to excess because they lose track of how many drinks have been consumed.

We typically advise patients and caregivers to limit alcohol consumption to low amounts (eg, one drink per sitting) and avoid after-dinner alcohol completely because of its detrimental effects on sleep. (See "Management of neuropsychiatric symptoms of dementia", section on 'Sleep disorders'.)

CAPACITY — Patients with dementia have a decreased ability to make decisions.

Decision-making capacity — Any illness or treatment that compromises cognition may be associated with reduced capacity. Decision-making capacity is broadly applicable and includes activities such as deciding how to interact with strangers, planning and prioritizing activities, and considering the choices in accepting medical therapy.

The likelihood of diminished capacity is related to the severity of cognitive impairment. However, brief measures of overall cognition such as the Mini-Mental State Examination (MMSE) are not a substitute for an assessment of capacity. While low scores (eg, <16 out of 30 points) in patients with dementia due to Alzheimer disease (AD) are highly correlated with impaired capacity, a higher score may or may not correlate with full capacity to make decisions. Among patients with mild- to moderate-stage dementia, verbal reasoning and verbal memory are the two cognitive domains that explain most of the performance on measures of capacity to consent. Measures of an individual's insight into their memory problems also correlate with decision-making capacity.

These and other issues related to the assessment of decision-making capacity in adults with dementia are reviewed separately. (See "Assessment of decision-making capacity in adults".)

Financial capacity — Financial capacity has been defined as the "ability to independently manage one's financial affairs in a manner consistent with personal self-interest" [22]. Impaired financial capacity can be the presenting clinical deficit in a patient with early dementia and can have serious consequences, with the potential for financial mismanagement and vulnerability to scams and exploitation.

Because impaired financial capacity can occur early in the course of dementia and is inevitable in all patients, it should be addressed relatively early after diagnosis with the patient and family/caregiver [23-26]. Recommendations include execution of a durable power of attorney, which can take effect immediately or in the future after impaired capacity has been demonstrated. Where available, there are dedicated financial planners and attorneys who specialize in helping older and cognitively impaired patients. Other practical interventions can include online banking, direct deposit, automatic bill pay, joint bank accounts, overdraft protections, and the use of living trusts [27].

While certain neuropsychological tests can help assess financial capacity (eg, Financial Capacity Instrument) [25], none of these instruments are well validated against financial outcomes or are likely to be, and none substitute for oversight from a trusted caregiver. When the latter is not available, a court-appointed conservator or guardian may need to be appointed. (See "Elder abuse, self-neglect, and related phenomena", section on 'Guardianship'.)

Patients and caregivers can be referred to the Alzheimer's Association (1-800-272-3900) for referrals regarding financial or legal planning. Other resources include the American Association of Retired Persons (AARP; 1-888-687-2277 [English] and 1-877-342-2277 [Spanish]) and the National Council on Aging BenefitsCheckUp service (1-202-479-1200).

Advance care planning — Advance care planning is critical to the management of patients with advanced dementia and should occur throughout the disease process [28,29].

The standard components of advance care planning apply to advanced dementia and are discussed separately. (See "Advance care planning and advance directives".)

In patients with dementia, we emphasize the following [30,31]:

Start early. Ideally, these discussions should begin before the patient loses decision-making capacity, thus allowing the individual to participate and articulate their wishes. Patients should be advised to appoint a health care proxy early in the process. (See "Assessment of decision-making capacity in adults".)

Talk about what is to come. As dementia progresses, patients experience not only loss of cognition and the ability to perform tasks of daily living. Later in the disease course, they will incur loss of basic bodily functions, particularly the ability to swallow and to fight infections. These complications are the most common proximate causes of death in advanced dementia. Later in the process, a Medical Orders for Life-Sustaining Treatment (MOLST) form can be helpful in addressing advance directives in a more granular manner.

As the disease progresses, referral for a palliative care consult can be helpful for families and caregivers. These conversations should occur in a stage-appropriate manner from the initial diagnosis. (See "Discussing goals of care".)

Consider using a structured conversation guide and written materials tailored to patients and caregivers with dementia [29,32]. Publicly available online resources include printable guides developed by The Conversation Project [32].

SUPPORT FOR CAREGIVERS — Caregivers of patients with dementia can suffer significant stress, particularly as cognitive function declines or behavioral symptoms worsen [33]. Counseling and participation in support groups can be beneficial. It is also helpful to encourage the caregiver to get help in sharing the caregiving burden with other family members or, if affordable, paid caregivers. Respite care and elder daycare may also be of benefit in providing a period of relief for caregivers [34] so that they can come back refreshed and rested. Respite care, daycare, and other day programs are available in most areas, often through the local agency on aging. In the United States, information can be obtained from the Alzheimer's Association at 1-800-272-3900.

While uncommon, caregivers can also become so frustrated with the constant vigilance required for care of the patient with dementia that they may verbally or physically abuse the patient. In either case, health care practitioners are mandated reporters and should notify older adult protection services. (See "Management of neuropsychiatric symptoms of dementia", section on 'Support for caregivers'.)

A variety of caregiver intervention studies have been performed, assessing both short-term and long-term outcomes, with mixed results. Most, but not all, have shown that counseling and support interventions benefit caregivers in the short term as measured by a reduction in stress and improvement in emotional wellbeing and quality of life [35-38]. As an example, a randomized trial that included 260 caregivers of individuals with dementia found that an eight-session educational program was associated with decreased caregiver anxiety and depression scores and improved quality of life over an eight-month period [37]. A randomized study using a different intervention (access to a volunteer "befriender" trained to give psychosocial support to caregivers) was less successful, and the majority of caregivers in the intervention group did not take up the volunteer [36].

Studies suggest that optimizing caregiver support might also help to keep patients with dementia cared for in the home and may reduce emergency department visits [38,39]. A meta-analysis of 13 studies of support programs for caregivers found that interventions designed to provide support for caregivers decreased the odds of institutionalization [39]. Among the heterogeneous and usually multicomponent interventions used, no specific type stood out as most effective. However, those that allowed individualization and choice by the caregiver seemed more effective than those that were more rigorously standardized.

In the United States, information can be obtained from the Alzheimer's Association at 1-800-272-3900. Information regarding frontotemporal dementia (FTD) can be found at the Association for Frontotemporal Degeneration.

SAFETY ISSUES — Safety issues are important aspects of the care of patients with dementia. Different safety concerns arise in a relatively predictable manner as dementia progresses. Addressing these issues proactively can prevent serious incidents.

Driving — It is important to ask patients whether or not they are driving and address safety concerns with the goal of assessing whether driving can continue safely.

Discussions of driving cessation are challenging. Surrendering a license often represents a severe loss of independence. Patients are generally unaware of their deficits (particularly their deficits in judgment) and are not accurate assessors of their driving ability. With early diagnosis, many patients with mild dementia will still be able to drive safely for a period of time, but all will eventually progress to the point where it is no longer safe to drive.

Driving risks in patients with dementia – In one survey, individuals with Alzheimer disease (AD) in the first year after diagnosis had a similar rate of crashes as registered drivers of all ages (0.068 and 0.067 per year, respectively), although higher than age-matched controls (0.037) [40]. The risk of crashes rose in the following years, to 0.159 by year 4. Other studies have been inconsistent in associating a higher rate of crashes with dementia [41]. One problem is that statistics of motor vehicle accidents may underrepresent the risk since older patients substantially reduce their driving [42].

However, studies of driving evaluations consistently demonstrate worse performance in patients with dementia compared with age-matched controls [41,42]. Impaired driving safety is associated with the degree of cognitive impairment as measured by neuropsychological test performance, in particular measures of overall cognition as well as more specific measures of visual perception and motor function [43,44]. As an example, in one prospective cohort study, older individuals who took more than 147 seconds to complete the Trails B test and those who took more than 352 ms on Useful Field of View subtest 2 were more than twice as likely to be involved in an at-fault motor vehicle accident [44].

Predictors of unsafe driving – A systematic review of studies that evaluated predictors of driving capacity in persons with dementia found that the clinical dementia rating (CDR) scale (table 2) had the best evidence of utility in evaluating driving safety [45]. Drivers with a CDR = 0 are in general safe to drive; patients with a CDR = 2 are considered unsafe to drive. Patients with a CDR of 0.5 or 1 have a higher risk of unsafe driving compared with those with a CDR = 0, but a substantial proportion (41 to 85 percent) will be judged to be safe drivers by an on-road driving evaluation.

Other predictors of unsafe driving have been identified [45]. It is important to note that these are more helpful in identifying drivers at risk; their absence does not identify a safe driver. Predictors of unsafe driving include:

Recent (one to five years) history of motor vehicle accident or citation

Self-restricted driving

Aggressive or impulsive behaviors

Caregiver's assessment of marginal or unsafe driving

Mini-Mental State Examination (MMSE) score of 24 or less

Recommendations for patients, families, and caregivers – An American Academy of Neurology practice parameter suggests an algorithm for evaluating driving safety in patients with dementia based upon the CDR (table 2) [45]:

Patients with a CDR = 2 are at high risk for unsafe driving. Patients and caregivers should be counseled to stop driving and interventions should be made pursuant to state guidelines unless the results of a driving assessment show retained capacity.

Patients with a CDR = 0.5 or 1 are at intermediate risk for unsafe driving. Considering this along with the other risk factors noted above, patients and families should be encouraged to develop alternative sources of transportation, to consider voluntary surrender of driving privileges if there are significant safety concerns, and to limit driving to daylight hours, to well-known locations, and to when driving conditions are good. Providers should consider a referral for a professional driving evaluation.

In general, there is no perfect correlation with bedside mental status tests and driving ability. In patients with CDRs of 0.5 to 1.0, it is often helpful to have them tested at on-the-road driving programs, or some virtual programs, dedicated to assessing driving ability.

Although a number of driving safety tests have been suggested, randomized studies have not been performed and no guidelines have been broadly implemented [46-49]. Observational data suggest that states with in-person renewal laws and/or mandatory road-side tests for older drivers have a lower proportion of dementia among hospitalized drivers after motor vehicle crashes, suggesting that such programs reduce the risk of dementia-related motor vehicle accidents [50]. Patients should be informed that even if they pass a driving evaluation, they will need to be retested at regular intervals as their disease progresses. Families and caregivers must be warned about potential liability for accidents. They may need to take possession of car keys, or even the cars, and restrict all driving.

Impaired cognition is only one factor limiting driving in older persons. Medications and sleep disorders, along with visual and motor impairments, should also be considered in assessing driving safety [45]. This topic is discussed in detail separately. (See "Approach to the evaluation of older drivers".)

Reporting requirements – Mandatory reporting of a moderate or severe dementia is required in some states in the United States (eg, California, Pennsylvania) as well as certain provinces in Canada and Australia [51]; however, these have not been shown to reduce the risk of dementia-related motor vehicle accidents [50]. It is important to remember that, where there are mandatory reporting laws, the clinicians need to familiarize themselves with the requirements of the law and report accordingly.

Falls — Falls are a major safety problem in some dementia syndromes, even early in the disease. The possibility of a parkinsonian syndrome should be considered if patients fall early in the course of illness. Whenever a patient is suspected of being a fall risk, a gait assessment is mandatory and can be done through a physical therapy consultation.

Falls eventually become a problem in all dementias. In one study of 1608 Swedish persons above the age of 75, the risk of hip fracture was twice as high when the score on the MMSE was suggestive of cognitive impairment (score 18 to 23) compared with those who had no impairment [52]. (See "The mental status examination in adults", section on 'Cognitive screening tests'.)

Patients who fall require careful evaluation to determine the etiology, with special attention to the possibility of a myelopathy (from cervical spondylosis or vitamin B12 deficiency), a peripheral neuropathy, or visual impairment. (See "Falls in older persons: Risk factors and patient evaluation".)

Behavioral disturbances — Behavioral disturbances can profoundly affect patients with dementia as well as their families and caregivers. Recognition and treatment of delusions, hallucinations, depression, agitation, aggression, and sleep disturbances are important aspects of the care of patients with dementia. This topic is discussed separately. (See "Management of neuropsychiatric symptoms of dementia" and "Sleep-wake disturbances and sleep disorders in patients with dementia".)

Wandering and becoming lost — Distractibility and restlessness may lead a patient with dementia to wandering. Memory loss and spatial impairment can cause a wandering patient to get lost, which has the potential for physical harm or death [53-57]. This is one of the concerns that often leads families and caregivers to place demented patients in nursing homes.

Risks – Becoming lost appears to be a highly unpredictable event and can occur even when individuals with dementia are in their own homes or are engaged in activities they had routinely performed many times in the past without incident.

Wandering and becoming lost has potential for physical harm or death. The risk of death is increased if the demented person ends up secluded in natural or sparsely populated areas [55]. Approximately 91 percent of persons with dementia who died were found in natural areas such as woods, fields, and bodies of water (nearly 22 percent drowned). The risk of death also appears to be associated with the hottest and coldest times of the year. The time it took to search for and locate a missing person with dementia also correlated with the risk of death; most individuals found alive were located within 24 hours, and all were found within four days.

All persons with dementia are at risk of becoming lost [57].

The risk may be higher for demented men than for women.

Individuals residing in professional care settings are at risk as well as those at home.

The risk of becoming lost is increased when demented persons are unattended, even in their own residences [57]. However, approximately 65 percent of people with dementia are in the presence of a caregiver at the time they become lost.

Wandering is only one risk factor for getting lost; individuals who had never wandered have become lost.

Preventive measures – Caregivers must be informed that all persons with dementia are at risk of becoming lost, even if the individual has never wandered or exhibited "risky" behavior in the past [57]. Signs on doors may reorient patients, and alarms may control movement. Regular supervised exercise can also lessen restlessness and the drive to wander.

Every effort should be made to ensure continuous supervision. Community resources, adult daycare and respite care facilities, and caregiver support groups may be utilized, if available, to reduce the burden on families and caregivers.

There are a number of commercially available tracking devices that use global positioning system (GPS).

Patients should carry identification, as persons with dementia often cannot remember their address, phone number, or possibly even their name. This information can facilitate return if a patient is lost. The Alzheimer's Association along with MedicAlert administers a 24/7 Wandering Support program with identification bracelet, necklace, or clothing tags and 24-hour assistance for patients who are enrolled in this program.

When a patient is lost – Caregivers should report the person missing immediately to local authorities (and to Wandering Support if registered).

Locating a person with dementia who becomes lost can be difficult [57]. People with dementia often behave in an unpredictable manner, rarely call for help or respond to searcher's calls, and often continue to wander. Search strategies should not be based on the individual characteristics of the missing person, since the unpredictable and abnormal behavior may negate any prior individual patterns [57].

The initial 6 to 12 hours of the search should cover a five-mile radius around the location where the lost person was last seen, concentrating on open, populated areas, including the inside of easily accessible buildings. If the person with dementia traveled by automobile, initial search efforts should focus on locating the vehicle. Subsequent efforts should be devoted to an intensive foot search of natural and sparsely populated areas beginning within a five-mile radius of the last known location and extending from there.

Home safety

Cooking — Distractibility, forgetfulness, or difficulty following directions could lead to injuries, burns, or fires during cooking.

We recommend early use of microwave ovens, particularly if the patient is unfamiliar with their use and may require instruction. Learning to use a new device will be easier early in the disease process.

Cutoff devices can be installed by the gas company or a plumber to prevent the use of a stove by a patient with specific memory loss.

Living alone — Living alone presents additional risks for people with cognitive impairment and dementia, as self-neglect, disorientation, and poor judgment may go unrecognized and unreported until there is a major problem or crisis [58]. However, few data exist regarding this population. The lack of data is exacerbated by the symptoms of cognitive impairment, which may cause this population to become disconnected from family, friends, and the health care system [58].

Identifying risk factors for harm in patients with dementia who live alone is an important goal. This problem was addressed by a prospective cohort study of 139 patients aged 65 or older with cognitive impairments who lived alone and were followed for 18 months [59]. Harm was defined as an episode of physical injury to self or others, or property loss or damage due to self-neglect or disorientation, resulting in need for emergency services. Four variables were significantly predictive of harm:

Self-perception of fewer social resources

Poorer performance on the MMSE

Presence of chronic obstructive pulmonary disease

Presence of cerebrovascular disease

Over the course of 18 months, 30 (22 percent) of the participants had an incident of harm; the most frequent was failure to eat and drink in nine cases. Only one incident of smoke damage and no incidents of wandering occurred, perhaps due to the small population size and relatively short period of follow-up. Further studies with larger sample sizes are needed to confirm the results of this investigation and to provide clinicians with reliable predictors of harm for patients with cognitive impairments who live alone.

If a clinician has reason to believe that a patient is in a state of self-neglect, appropriate reporting should be promptly initiated. Adult protective services agencies and the courts are obliged to use the least-restrictive alternative when an individual's autonomy is impacted in order to protect that person. Recognition and management of elder mistreatment, which includes self-neglect, is reviewed in more detail separately. (See "Elder abuse, self-neglect, and related phenomena".)

END-OF-LIFE ISSUES — In the terminal stages of dementia, patients and their caregivers are faced with a range of physical and psychosocial needs, and effective palliative care can improve patients' symptoms, lessen caregiver burden, and help ensure that treatment decisions are well informed and weighed in the context of patient and caregiver goals and needs. Aspects of palliative care that are specific to patients with advanced dementia are discussed separately. (See "Care of patients with advanced dementia".)

It is important that advance care planning begins shortly after the diagnosis of dementia when impairments are not advanced. In this way, patients can participate in decision-making, and families and caregivers know what to expect. Specific aspects of this planning are discussed in detail separately. (See "Care of patients with advanced dementia", section on 'Advance care planning'.)

LIFE EXPECTANCY — Dementia shortens life expectancy, although actual survival estimates have varied in different reports. Length bias complicates the interpretation of many studies by failing to consider patients with rapidly progressive illness who died before they could be included in the study. Another complicating factor is that patients are diagnosed at different stages in their illness.

In a study that adjusted for length bias, a random sample of 10,263 subjects age 65 and older from the Canadian Study of Health and Aging were screened for dementia and followed for five years [60]. The adjusted median survival for patients with probable Alzheimer disease (AD), possible AD, and vascular dementia was 3.1, 3.5, and 3.3 years, respectively. A younger age at onset was associated with longer survival, a finding consistent with prospective follow-up of participants in the Baltimore Longitudinal Study of Aging who were age 55 years and older [61]. In this report, the median survival of patients with AD ranged from almost nine years for patients diagnosed at age 65 (an approximate 67 percent reduction in median lifespan) to approximately three years for those diagnosed at age 90 (a 39 percent reduction in median survival).

These estimates will vary depending upon individual patient characteristics. Patients with dementia are more likely to be hospitalized than age-matched controls [62-65]. In one longitudinal cohort study, individuals with dementia had higher rates of hospital admission for bacterial pneumonia, congestive heart failure, dehydration, duodenal ulcer, and urinary tract infections, among other diagnoses, compared with those who did not have dementia [66]. Pneumonia, febrile episodes, delirium, and eating problems are common in advanced dementia and are associated with increased mortality [28], although accurate prediction of survival in patients with advanced dementia remains difficult. (See "Care of patients with advanced dementia", section on 'Life expectancy and hospice eligibility'.)

End-of-life issues, hospice, and palliative care in patients with advanced dementia are discussed separately. (See "Care of patients with advanced dementia".)

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Cognitive impairment and dementia".)

INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.

Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)

Basics topics (see "Patient education: Dementia (including Alzheimer disease) (The Basics)" and "Patient education: Tips for caregivers of people with Alzheimer disease (The Basics)")

Beyond the Basics topics (see "Patient education: Dementia (including Alzheimer disease) (Beyond the Basics)")

SUMMARY AND RECOMMENDATIONS

Specialty referral – The first step in management is an accurate diagnosis of the type of dementia. Thus, uncertainty about the specific diagnosis requires early referral to a specialist. Other indications for specialty referral depend upon the experience of the primary care provider in managing dementia and on the availability of specialty clinics where additional resources are available. (See 'Specialty-care referral' above.)

Medical care – Medical treatment of patients with dementia includes disease-specific medical treatments when appropriate and management of vascular risk factors.

It is important to limit polypharmacy and avoid medications, particularly those with anticholinergic properties, that can affect cognition (table 1). Medications lists should be reviewed periodically for necessity, and new drugs should be prescribed with caution. (See 'Medical therapy' above.)

While nonpharmacologic approaches have advantages in avoiding side effects that complicate drug treatment, more research is needed to confirm benefits and to provide a standardized approach. (See 'Nonpharmacologic therapy and supportive care' above.)

Behavioral disturbances – Aggressive behavior may present a risk to the caregiver as well as to the patient. Caregivers may be embarrassed to volunteer this problem, and this history should be solicited. The treatment of aggressive behavior is discussed separately. (See "Management of neuropsychiatric symptoms of dementia".)

Decision-making capacity – In the presence of cognitive impairment, determining whether a patient has adequate capacity is critical to striking the proper balance between respecting patient autonomy and acting in a patient's best interest. Brief tests of cognition in patients with dementia are not a substitute for a formal assessment of capacity. (See "Assessment of decision-making capacity in adults".)

Because diminished capacity is inevitable, advance care planning is critical. Discussions should begin early in the disease process when possible. (See 'Advance care planning' above.)

Driving – Driving becomes unsafe as cognition deteriorates. Patients with a clinical dementia rating (CDR) score ≥2 are considered unsafe to drive (table 2). Patients with a CDR = 0.5 or 1 should undergo further risk assessment, based upon identified risk factors and/or an on-road driving evaluation. (See 'Driving' above.)

Wandering – Some patients with dementia wander and may become lost, with an attendant risk of personal harm and even death. This can occur when a patient lives at home and when residing in a professional care center. Supervision, identification tags, and registration with Wandering Support or similar programs may ameliorate risk. (See 'Wandering and becoming lost' above.)

Falls – Falls eventually become a problem in all dementias but can be a problem early on in the dementias that are associated with parkinsonism (eg, dementia with Lewy bodies, Parkinson disease [PD] dementia). Patients and caregivers should be asked about falling, which may be an indication for providing increased supervision. (See 'Falls' above.)

Caregiver support – Caregivers of patients with dementia can suffer significant stress. Respite care and support groups are available in most areas, often through the local agency on aging. (See "Management of neuropsychiatric symptoms of dementia", section on 'Support for caregivers'.)

End-of-life issues – Advance directives and other advance care planning should be discussed prior to the onset of moderate or severe dementia when possible. Palliative and hospice care can benefit patients with severe dementia at the end of their lives. (See "Care of patients with advanced dementia".)

ACKNOWLEDGMENT — The UpToDate editorial staff acknowledges Michael Alexander, MD, who contributed to an earlier version of this topic review.

  1. Brauner DJ, Muir JC, Sachs GA. Treating nondementia illnesses in patients with dementia. JAMA 2000; 283:3230.
  2. Karlawish JH, Casarett DJ, James BD, et al. The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment. Neurology 2005; 64:1514.
  3. Pruchno RA, Smyer MA, Rose MS, et al. Competence of long-term care residents to participate in decisions about their medical care: a brief, objective assessment. Gerontologist 1995; 35:622.
  4. Sabayan B, Westendorp RG. Blood pressure control and cognitive impairment--why low is not always better. JAMA Intern Med 2015; 175:586.
  5. Mossello E, Pieraccioli M, Nesti N, et al. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. JAMA Intern Med 2015; 175:578.
  6. Centi J, Freeman R, Gibbons CH, et al. Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology 2017; 88:17.
  7. Sura SD, Carnahan RM, Chen H, Aparasu RR. Prevalence and determinants of anticholinergic medication use in elderly dementia patients. Drugs Aging 2013; 30:837.
  8. Thorpe JM, Thorpe CT, Gellad WF, et al. Dual Health Care System Use and High-Risk Prescribing in Patients With Dementia: A National Cohort Study. Ann Intern Med 2017; 166:157.
  9. White H. Weight change in Alzheimer's disease. J Nutr Health Aging 1998; 2:110.
  10. Lauque S, Arnaud-Battandier F, Gillette S, et al. Improvement of weight and fat-free mass with oral nutritional supplementation in patients with Alzheimer's disease at risk of malnutrition: a prospective randomized study. J Am Geriatr Soc 2004; 52:1702.
  11. Hanson LC, Ersek M, Gilliam R, Carey TS. Oral feeding options for people with dementia: a systematic review. J Am Geriatr Soc 2011; 59:463.
  12. Woods B, Aguirre E, Spector AE, Orrell M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev 2012; :CD005562.
  13. Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 2015; 385:2255.
  14. Forbes D, Forbes SC, Blake CM, et al. Exercise programs for people with dementia. Cochrane Database Syst Rev 2015; :CD006489.
  15. Teri L, Gibbons LE, McCurry SM, et al. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA 2003; 290:2015.
  16. Rolland Y, Pillard F, Klapouszczak A, et al. Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial. J Am Geriatr Soc 2007; 55:158.
  17. Pitkälä KH, Pöysti MM, Laakkonen ML, et al. Effects of the Finnish Alzheimer disease exercise trial (FINALEX): a randomized controlled trial. JAMA Intern Med 2013; 173:894.
  18. Öhman H, Savikko N, Strandberg TE, et al. Effects of Exercise on Cognition: The Finnish Alzheimer Disease Exercise Trial: A Randomized, Controlled Trial. J Am Geriatr Soc 2016; 64:731.
  19. Lamb SE, Sheehan B, Atherton N, et al. Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial. BMJ 2018; 361:k1675.
  20. Graff MJ, Vernooij-Dassen MJ, Thijssen M, et al. Community based occupational therapy for patients with dementia and their care givers: randomised controlled trial. BMJ 2006; 333:1196.
  21. Graff MJ, Adang EM, Vernooij-Dassen MJ, et al. Community occupational therapy for older patients with dementia and their care givers: cost effectiveness study. BMJ 2008; 336:134.
  22. Marson DC, Hebert T. Financial Capacity. In: Encyclopedia of Psychiatry and the Law, Cutler BL (Ed), Sage, Thousand Oaks, CA 2008. Vol 1, p.313.
  23. Martin R, Griffith HR, Belue K, et al. Declining financial capacity in patients with mild Alzheimer disease: a one-year longitudinal study. Am J Geriatr Psychiatry 2008; 16:209.
  24. Triebel KL, Martin R, Griffith HR, et al. Declining financial capacity in mild cognitive impairment: A 1-year longitudinal study. Neurology 2009; 73:928.
  25. Griffith HR, Belue K, Sicola A, et al. Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Neurology 2003; 60:449.
  26. Okonkwo OC, Wadley VG, Griffith HR, et al. Cognitive correlates of financial abilities in mild cognitive impairment. J Am Geriatr Soc 2006; 54:1745.
  27. Widera E, Steenpass V, Marson D, Sudore R. Finances in the older patient with cognitive impairment: "He didn't want me to take over". JAMA 2011; 305:698.
  28. Mitchell SL, Teno JM, Kiely DK, et al. The clinical course of advanced dementia. N Engl J Med 2009; 361:1529.
  29. Gaster B, Larson EB, Curtis JR. Advance Directives for Dementia: Meeting a Unique Challenge. JAMA 2017; 318:2175.
  30. Mitchell SL. CLINICAL PRACTICE. Advanced Dementia. N Engl J Med 2015; 372:2533.
  31. Piers R, Albers G, Gilissen J, et al. Advance care planning in dementia: recommendations for healthcare professionals. BMC Palliat Care 2018; 17:88.
  32. https://theconversationproject.org/starter-kits/.
  33. Aarsland D, Brønnick K, Ehrt U, et al. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 2007; 78:36.
  34. Nichols LO, Martindale-Adams J, Burns R, et al. Translation of a dementia caregiver support program in a health care system--REACH VA. Arch Intern Med 2011; 171:353.
  35. Belle SH, Burgio L, Burns R, et al. Enhancing the quality of life of dementia caregivers from different ethnic or racial groups: a randomized, controlled trial. Ann Intern Med 2006; 145:727.
  36. Charlesworth G, Shepstone L, Wilson E, et al. Befriending carers of people with dementia: randomised controlled trial. BMJ 2008; 336:1295.
  37. Livingston G, Barber J, Rapaport P, et al. Clinical effectiveness of a manual based coping strategy programme (START, STrAtegies for RelaTives) in promoting the mental health of carers of family members with dementia: pragmatic randomised controlled trial. BMJ 2013; 347:f6276.
  38. Possin KL, Merrilees JJ, Dulaney S, et al. Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized Clinical Trial. JAMA Intern Med 2019; 179:1658.
  39. Spijker A, Vernooij-Dassen M, Vasse E, et al. Effectiveness of nonpharmacological interventions in delaying the institutionalization of patients with dementia: a meta-analysis. J Am Geriatr Soc 2008; 56:1116.
  40. Drachman DA, Swearer JM. Driving and Alzheimer's disease: the risk of crashes. Neurology 1993; 43:2448.
  41. Man-Son-Hing M, Marshall SC, Molnar FJ, Wilson KG. Systematic review of driving risk and the efficacy of compensatory strategies in persons with dementia. J Am Geriatr Soc 2007; 55:878.
  42. Ott BR, Heindel WC, Papandonatos GD, et al. A longitudinal study of drivers with Alzheimer disease. Neurology 2008; 70:1171.
  43. Dawson JD, Anderson SW, Uc EY, et al. Predictors of driving safety in early Alzheimer disease. Neurology 2009; 72:521.
  44. Ball KK, Roenker DL, Wadley VG, et al. Can high-risk older drivers be identified through performance-based measures in a Department of Motor Vehicles setting? J Am Geriatr Soc 2006; 54:77.
  45. Iverson DJ, Gronseth GS, Reger MA, et al. Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2010; 74:1316.
  46. Hunt LA, Murphy CF, Carr D, et al. Reliability of the Washington University Road Test. A performance-based assessment for drivers with dementia of the Alzheimer type. Arch Neurol 1997; 54:707.
  47. Fitten LJ, Perryman KM, Wilkinson CJ, et al. Alzheimer and vascular dementias and driving. A prospective road and laboratory study. JAMA 1995; 273:1360.
  48. Cushman LA, Stein K, Duffy CJ. Detecting navigational deficits in cognitive aging and Alzheimer disease using virtual reality. Neurology 2008; 71:888.
  49. Martin AJ, Marottoli R, O'Neill D. Driving assessment for maintaining mobility and safety in drivers with dementia. Cochrane Database Syst Rev 2013; :CD006222.
  50. Agimi Y, Albert SM, Youk AO, et al. Dementia and motor vehicle crash hospitalizations: Role of physician reporting laws. Neurology 2018; 90:e808.
  51. Rapoport MJ, Herrmann N, Molnar FJ, et al. Sharing the responsibility for assessing the risk of the driver with dementia. CMAJ 2007; 177:599.
  52. Guo Z, Wills P, Viitanen M, et al. Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol 1998; 148:887.
  53. Rowe MA, Glover JC. Antecedents, descriptions and consequences of wandering in cognitively-impaired adults and the Safe Return (SR) program. Am J Alzheimers Dis Other Demen 2001; 16:344.
  54. Koester RJ. The lost Alzheimer's and related disorders search subject: new research and perspectives. In: Response 98 NASAR Proceedings, Chantilly, Virginia, National Association of Search and Rescue, 1998. p.161.
  55. Rowe MA, Bennett V. A look at deaths occurring in persons with dementia lost in the community. Am J Alzheimers Dis Other Demen 2003; 18:343.
  56. Rowe MA. People with dementia who become lost. Am J Nurs 2003; 103:32.
  57. Rowe MA, Feinglass NG, Wiss ME. Persons with dementia who become lost in the community: a case study, current research, and recommendations. Mayo Clin Proc 2004; 79:1417.
  58. Soniat BA. Dementia patients who live alone: research and clinical challenges. J Am Geriatr Soc 2004; 52:1576.
  59. Tierney MC, Charles J, Naglie G, et al. Risk factors for harm in cognitively impaired seniors who live alone: a prospective study. J Am Geriatr Soc 2004; 52:1435.
  60. Wolfson C, Wolfson DB, Asgharian M, et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 2001; 344:1111.
  61. Brookmeyer R, Corrada MM, Curriero FC, Kawas C. Survival following a diagnosis of Alzheimer disease. Arch Neurol 2002; 59:1764.
  62. Tuppin P, Kusnik-Joinville O, Weill A, et al. Primary health care use and reasons for hospital admissions in dementia patients in france: database study for 2007. Dement Geriatr Cogn Disord 2009; 28:225.
  63. Malone DC, McLaughlin TP, Wahl PM, et al. Burden of Alzheimer's disease and association with negative health outcomes. Am J Manag Care 2009; 15:481.
  64. Natalwala A, Potluri R, Uppal H, Heun R. Reasons for hospital admissions in dementia patients in Birmingham, UK, during 2002-2007. Dement Geriatr Cogn Disord 2008; 26:499.
  65. Zhao Y, Kuo TC, Weir S, et al. Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's. BMC Health Serv Res 2008; 8:108.
  66. Phelan EA, Borson S, Grothaus L, et al. Association of incident dementia with hospitalizations. JAMA 2012; 307:165.
Topic 5080 Version 27.0

References